Predictive models for recurrence risk of hepatocellular carcinoma after liver transplantation: Still an unmet need
Authors:
- 28 April 2017
- journal article
- Published by Wiley in Liver International
- Vol. 37 (5) , 648-650
Abstract
No abstract availableFunding Information
- National Institute of Cancer (INC), Argentina
This publication has 20 references indexed in Scilit:
- Validation of a Risk Estimation of Tumor Recurrence After Transplant (RETREAT) Score for Hepatocellular Carcinoma Recurrence After Liver TransplantJAMA Oncology, 2017
- Prediction of hepatocellular carcinoma recurrence after liver transplantation: Comparison of four explant‐based prognostic modelsLiver International, 2017
- The extended Toronto criteria for liver transplantation in patients with hepatocellular carcinoma: A prospective validation studyHepatology, 2016
- Liver transplantation for hepatocellular carcinoma: evaluation of the alpha‐fetoprotein model in a multicenter cohort from Latin AmericaLiver International, 2016
- Serum alpha-fetoprotein level independently predicts posttransplant survival in patients with hepatocellular carcinomaLiver Transplantation, 2013
- Liver Transplantation for Hepatocellular Carcinoma: A Model Including α-Fetoprotein Improves the Performance of Milan CriteriaGastroenterology, 2012
- Increasing disparity in waitlist mortality rates with increased model for end-stage liver disease scores for candidates with hepatocellular carcinoma versus candidates without hepatocellular carcinoma#*Liver Transplantation, 2012
- Milan criteria in liver transplantation for hepatocellular carcinoma: An evidence-based analysis of 15 years of experienceLiver Transplantation, 2011
- Liver Transplantation for Hepatocellular Carcinoma: Beyond the Milan CriteriaAmerican Journal of Transplantation, 2008
- Total tumor volume predicts risk of recurrence following liver transplantation in patients with hepatocellular carcinomaLiver Transplantation, 2008